Hologic's Q2 revenue forecast is slightly below the analyst estimates, which could indicate a minor negative impact on investor sentiment. However, the adjusted EPS forecast is very close to the estimates, suggesting that the company's profitability is in line with expectations. This mixed forecast might lead to a neutral short-term impact on HOLX's stock price, as the slight miss in revenue expectations could be offset by the alignment of EPS with estimates.